参考文献/References:
[1] 张卫东.一种盐酸莫西沙星中间体的制备方法:CN 102399219A [P].2012-04-04.
[2] Schaerrer A J.The expending role of fluoroquimolones [J].Am J Med,2002,113:45-54.
[3] Schmitz F J,Boss M,Mayr S.Propensity of fluoroquinolones with different moietiesat position 8 to cause resistance development in clinical isolates of streptococcus neumoniae [J].Antimicrob Agents Chemother,2002,45(9):2666-2667.
[4] Wakefieild B.Fluorinated pharmaceuticals [J].Pharmaceut Tech,2000,74(1):76 -78.
[5] Mather R,Karenchak I M,Romanowski E G.Fourth generation fluoroquinolones:new weapons in thearsenal of ophthalminantibiotics [J].Am J Ophthalmol,2002,133(4):463-466.
[6] 徐丹丹.莫西沙星中间体的合成 [J].精细与专用化学品,2011,19(1):43-44.
[7] 崔栋.莫西沙星侧链的合成 [J].浙江化工,2013,44(8):5-9.
[8] 郭勇.一种莫西沙星中间体的制备方法:CN 103588772 A [P].2014-02-19.
[9] 喻理德.受体酪氨基酸激酶抑制剂的合成 [J].江西师范大学学报:自然科学版,2013,37(2):152-154.